Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Scholars @ UT Health San Antonio Inicio
Ayuda y preguntas frecuentes
English
Español
Inicio
Perfiles
Unidades de investigación
Producción científica
Conjuntos de datos
Buscar por experiencia, nombre o afiliación
Practice guidelines for diseases caused by Aspergillus
David A. Stevens
, Virginia L. Kan
, Marc A. Judson
, Vicki A. Morrison
, Stephen Dummer
, David W. Denning
, John E. Bennett
, Thomas J. Walsh
,
Thomas F. Patterson
, George A. Pankey
Division of Infectious Diseases
Producción científica
:
Review article
›
revisión exhaustiva
771
Citas (Scopus)
Información general
Huella
Huella
Profundice en los temas de investigación de 'Practice guidelines for diseases caused by Aspergillus'. En conjunto forman una huella única.
Clasificar por
Ponderación
Alfabéticamente
Medicine and Dentistry
Adjuvant Therapy
14%
Allergic Bronchopulmonary Aspergillosis
28%
Amphotericin
42%
Amphotericin B Deoxycholate
14%
Antifungal Agent
14%
Arterial Embolization
14%
Aspergilloma
71%
Aspergillosis
14%
Aspergillus
28%
Base
14%
Bronchial Artery
14%
Chemotherapeutic Agent
28%
Clotiazepam
14%
Combination Chemotherapy
14%
Combination Therapy
100%
Consensus
14%
Corticosteroid
71%
Corticosteroid Therapy
14%
Creatinine
14%
Deoxycholic Acid
14%
Diagnosis
14%
Disease Course
14%
Disease Predisposition
14%
Diseases
71%
Drug
28%
Drug Therapy
14%
Experience
14%
Health Care Cost
14%
Hemoptysis
57%
Immunocompromised Patient
28%
Immunoglobulin E
14%
Immunotherapy
14%
Infection
14%
Inpatient
14%
Intravenous Drug Administration
14%
Invasive Aspergillosis
28%
Itraconazole
57%
Kidney Function
14%
Life
57%
Lipid
14%
Lung Function
14%
Lung Injury
14%
Monitoring
14%
Morbidity
28%
Mortality
14%
Nephrotoxicity
14%
Organ Systems
14%
Paracetamol
14%
Patient
100%
Personal Experience
14%
Prednisone
14%
Reading
14%
Sarcoidosis
14%
Serum
42%
Silo-Filler's Disease
14%
Spirometry
14%
Student
14%
Surgery
28%
Symptom
14%
Therapeutic Procedure
42%
Thorax Radiography
14%
Treatment Duration
14%
Pharmacology, Toxicology and Pharmaceutical Science
Allergic Bronchopulmonary Aspergillosis
28%
Amphotericin
42%
Amphotericin B Deoxycholate
14%
Antifungal Agent
14%
Aspergilloma
71%
Aspergillosis
14%
Aspergillus
28%
Base
14%
Clotiazepam
14%
Corticosteroid
71%
Creatinine
14%
Deoxycholic Acid
14%
Disease Course
14%
Disease Predisposition
14%
Diseases
71%
Drug
28%
Hemoptysis
57%
Immunocompromised Patient
28%
Immunoglobulin E
14%
Immunotherapy
14%
Infection
14%
Intravenous Therapy
14%
Invasive Aspergillosis
28%
Itraconazole
57%
Lipid
14%
Lung Disease
14%
Lung Injury
14%
Maximum Tolerated Dose
14%
Morbidity
28%
Mortality
14%
Nephrotoxicity
14%
Paracetamol
14%
Prednisone
14%
Sarcoidosis
14%
Symptom
14%